Preliminary, unaudited revenue for the full year 2024 of approximately $174 million
Presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16th, 2024, at 9:45 a.m. PT.
https://finance.yahoo.com/news/standard-biotools-announces-preliminary-fourth-120000341.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.